Research
1981
201-500 Employees
Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEMFraunhofer ITEM aims to protect man from health hazards in our industrialized world and to contribute to the development of novel therapeutic approaches. Focusing on lung and inhalation, Fraunhofer ITEM in Hanover has pooled its expertise in three business areas:
In the business area Drug Development, we develop and test novel medications against respiratory diseases – in particular asthma, hay fever, COPD, idiopathic pulmonary fibrosis (IPF) and infections. The scientific expertise covers both preclinical research in pharmacology and toxicology as well as clinical development.
In the business area Chemical Safety and Assessment we determine the risks from potentially harmful substances and support the development of new products to protect human health and the environment. Scientific expertise includes toxicology testing, exposure assessment, analytical methods, regulatory research and risk assessment.
The business area Translational Biomedical Engineering offers many years of experience in the development of medical devices – specifically medical aerosolizers and neuro-implants – including testing and testing scenarios, safety and risk assessment.
All business areas offer regulatory support. Numerous test systems are available, including in-vitro, ex-vivo, in-vivo and in-silico models. Studies can be performed in compliance with GXP regulations.
A Regensburg-based division is dedicated to personalized tumor therapy including development of diagnostic tests to enable early detection of disseminated cancer cells and prediction of the response to therapy of metastatic progenitor cells.
In the business area Drug Development, we develop and test novel medications against respiratory diseases – in particular asthma, hay fever, COPD, idiopathic pulmonary fibrosis (IPF) and infections. The scientific expertise covers both preclinical research in pharmacology and toxicology as well as clinical development.
In the business area Chemical Safety and Assessment we determine the risks from potentially harmful substances and support the development of new products to protect human health and the environment. Scientific expertise includes toxicology testing, exposure assessment, analytical methods, regulatory research and risk assessment.
The business area Translational Biomedical Engineering offers many years of experience in the development of medical devices – specifically medical aerosolizers and neuro-implants – including testing and testing scenarios, safety and risk assessment.
All business areas offer regulatory support. Numerous test systems are available, including in-vitro, ex-vivo, in-vivo and in-silico models. Studies can be performed in compliance with GXP regulations.
A Regensburg-based division is dedicated to personalized tumor therapy including development of diagnostic tests to enable early detection of disseminated cancer cells and prediction of the response to therapy of metastatic progenitor cells.
Address
Nikolai-Fuchs-Straße 1, 30625 Hanover, Germany
Commercial Register
e.V.
VR 4461
Events
In this section you can see events in which the organization participates.
03.11.2026, 16:45 (GMT+01:00)
Innovationspreis NiedersachsenFor the 10th time this year, the Innovationspreis Niedersachsen will be awarded.The Niedersachsen.next Innovationsnetzwerk, together with the Lower Saxony Ministry of Economic Affairs, Transport and Construction and the Lower Saxony Ministry of Science and Culture, honors outstanding ideas, innovative developments, and special collaborations.Be there on November 3rd when this year's award winners are honored and we celebrate the innovative strength of Lower Saxony together.The award ceremony will take place on 3.11. from 5 p.m. in Hanover. More information will follow.
OL
24.11.2026, 10:00 (GMT+01:00)
Jahresnetzwerktreffen der Niedersachsen.next Automotive Agentur 2026Save the DateMerken Sie sich bereits jetzt den Termin für das Jahresnetzwerktreffen der Niedersachsen.next Automotive Agentur vor.Am 24. November 2026 kommen Vertreter*innen der Automobil- und Mobilitätsbranche, Unternehmen, Forschungseinrichtungen, Verbände, Multiplikator*innen sowie politische Akteur*innen in Hannover zusammen, um aktuelle Entwicklungen, Herausforderungen und Zukunftsperspektiven der Branche zu diskutieren und neue Kontakte zu knüpfen.Transformation gemeinsam gestaltenDie Automobilindustrie befindet sich in einem tiefgreifenden Wandel. Technologische Entwicklungen, veränderte Marktbedingungen sowie geopolitische und wirtschaftliche Rahmenbedingungen erfordern neue Perspektiven und strategische Antworten.Für viele Unternehmen stellt sich die Frage, wie bestehende Kompetenzen und Technologien künftig in weiteren Branchen und Märkten eingesetzt werden können. Gleichzeitig gilt es, bestehende Wertschöpfungsketten resilient aufzustellen und neue Chancen für Wachstum und Innovation zu erschließen.Das Jahresnetzwerktreffen bietet den Rahmen, um gemeinsam über diese Entwicklungen zu sprechen, neue Impulse zu gewinnen und Erfahrungen auszutauschen.Darauf können Sie sich freuen🔹 Austausch mit Akteur*innen aus der Automobil- und Mobilitätswirtschaft🔹 Einblicke in aktuelle Entwicklungen und Transformationsprozesse🔹 Praxisbeispiele und Best Practices aus Unternehmen und Projekten🔹 Vernetzung mit regionalen Multiplikator*innen🔹 Dialog mit politischen Entscheidungsträger*innenWeitere Informationen folgenDie Inhalte des Programms sowie Informationen zu Speaker*innen und weiteren Programmpunkten werden in den kommenden Monaten veröffentlicht.Wir freuen uns darauf, Sie am 24. November 2026 in Hannover begrüßen zu dürfen.
LW